Search research articles
Contact Us
Filters
Showing results (11-20 of 96) with videos related to
Page
of 10
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 25, 2009
Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase
S Dollfus, M Petit
L'Encephale
|
March 1, 1990
[Biochemical effects of neuroleptics]
M Petit, S Dollfus
L'Encephale
|
July 10, 2018
[Physical activity in patients with schizophrenia: From neurobiology to clinical benefits]
M Tréhout, S Dollfus
L'Encephale
|
October 1, 1986
[Biochemical factors of resistance to antidepressants]
M Petit, S Dollfus
Annales De Pediatrie
|
November 1, 1988
[Chemotherapy principles of severe somatic expressions of anxiety in adolescents]
S Dollfus, M Petit
L'Encephale
|
September 1, 1992
[A critical study of conditions for prescription and evaluation criteria of neuroleptic treatment in resistant schizophrenia]
M Petit, S Dollfus
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 25, 2009
Stability of positive and negative symptoms in schizophrenic patients: a 3-year follow-up study
S Dollfus, M Petit
Psychopathology
|
June 24, 1998
Symptom structure in schizophrenia: two-, three- or four-factor models?
S Dollfus, B Everitt
Schizophrenia Research
|
October 1, 1995
Negative symptoms in schizophrenia: their evolution during an acute phase
S Dollfus, M Petit
L'Encephale
|
June 1, 1996
[Stability of positive/negative symptoms in schizophrenia]
J M Ribeyre, S Dollfus
Page
of 10
Search research articles
Search
Showing results (11-20 of 96) with videos related to
Sort By:
Page
of 10
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 25, 2009
Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase
S Dollfus, M Petit
L'Encephale
|
March 1, 1990
[Biochemical effects of neuroleptics]
M Petit, S Dollfus
L'Encephale
|
July 10, 2018
[Physical activity in patients with schizophrenia: From neurobiology to clinical benefits]
M Tréhout, S Dollfus
L'Encephale
|
October 1, 1986
[Biochemical factors of resistance to antidepressants]
M Petit, S Dollfus
Annales De Pediatrie
|
November 1, 1988
[Chemotherapy principles of severe somatic expressions of anxiety in adolescents]
S Dollfus, M Petit
L'Encephale
|
September 1, 1992
[A critical study of conditions for prescription and evaluation criteria of neuroleptic treatment in resistant schizophrenia]
M Petit, S Dollfus
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 25, 2009
Stability of positive and negative symptoms in schizophrenic patients: a 3-year follow-up study
S Dollfus, M Petit
Psychopathology
|
June 24, 1998
Symptom structure in schizophrenia: two-, three- or four-factor models?
S Dollfus, B Everitt
Schizophrenia Research
|
October 1, 1995
Negative symptoms in schizophrenia: their evolution during an acute phase
S Dollfus, M Petit
L'Encephale
|
June 1, 1996
[Stability of positive/negative symptoms in schizophrenia]
J M Ribeyre, S Dollfus
Page
of 10